Clinical Trial

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population. Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-30.
Trial Details
NCT Number NCT06115122
Lead Sponsor Oulu University Hospital
Collaborators: PerkinElmer, Inc., Roche Diagnostics GmbH, Academy of Finland, Sigrid Jusélius Foundation, Finnish Medical Foundation, University of Oulu
Conditions Pre-Eclampsia, Intrauterine Growth Restriction, Polycystic Ovary Syndrome, Iron-deficiency, Cardiovascular Diseases, Hypertensive Disorder of Pregnancy, Proteinuria in Pregnancy
Enrollment 3,000 participants
Start Date 2022-02-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2041-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-05